ProMetic Life Sciences operates through a group of subsidiaries to specialize in the design of small molecules that mimic unique and specific interactions between proteins. The company’s technologies are applicable to large-scale drug purification, drug development, proteomics and the elimination of pathogens. PLI is also developing novel therapeutics targeting unmet medical needs in the field of fibrosis, anemia, neutropenia, cancer, and autoimmune disease/inflammation as well as certain nephropathies. For further information, visit the company’s Web site at www.prometic.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: